The Quantum-Enabled Predictive Preclinical NAMs for Toxicity and Safety (QuSAFE) Challenge, a collaboration between the National Institutes of Health (NIH) and NASA, advances quantum-enabled sensing for in vitro NAMs, such as organoids and microphysiological systems (MPS), to improve drug safety while reducing animal use. In vitro NAMs, such as organoids and microphysiological systems (MPS), can […]
NIH and NASA Collaborate on Quantum-Enabled Drug Safety Challenge
The NIH and NASA have launched the QuSAFE Challenge to enhance drug safety through quantum-enabled sensing technologies, aiming to reduce animal testing. This initiative focuses on in vitro NAMs like organoids and microphysiological systems. For Iran, advancements in drug safety and reduced reliance on animal testing could influence local biomedical research and regulatory practices.
👥 Key Players
📰 What Happened
The NIH and NASA have launched the QuSAFE Challenge to enhance drug safety using quantum-enabled technologies, aiming to reduce reliance on animal testing. This initiative focuses on developing in vitro models to improve drug safety assessments.
- The challenge promotes the use of quantum-enabled sensing technologies.
- It emphasizes the development of in vitro models like organoids and microphysiological systems.
💡 Why It Matters
📚 Background
The use of in vitro models is gaining traction in biomedical research as a way to reduce animal testing and improve safety assessments. Quantum technologies are emerging as a powerful tool in this field.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%